Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.
Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.
复制标题
DOI:
10.1186/1471-2407-8-123
复制
发表时间:
2008-05-01
期刊:
影响因子:
3.8
通讯作者:
Kim, Hyo-Jin
中科院分区:
文献类型:
--
作者:
Oh, Sung Yong;Kwon, Hyuk-Chan;Kim, Sung-Hyun;Jang, Jin Seok;Kim, Min Chan;Kim, Kyeong Hee;Han, Jin-Yeong;Kim, Chung Ock;Kim, Su-Jin;Jeong, Jin-sook;Kim, Hyo-Jin
Hypoxia influences tumor growth by inducing angiogenesis and genetic alterations. Hypoxia-inducible factor 1α (HIF-1α), p53, and vascular endothelial growth factor (VEGF) are all important factors in the mechanisms inherent to tumor progression. In this work, we have investigated the clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF (sVEGF) level in gastric cancer. We immunohistochemically assessed the HIF-1α, p53, and VEGF expression patterns in 114 specimens of gastric cancer. Additionally, we determined the levels of preoperative serum VEGF (sVEGF). The positive rates of p53 and HIF-1α (diffuse, deep, intravascular pattern) were 38.6% and 15.8%, respectively. The VEGF overexpression rate was 57.9%. p53 and HIF-1α were correlated positively with the depth of invasion (P = 0.015, P = 0.001, respectively). Preoperative sVEGF and p53 levels were correlated significantly with lymph node involvement (P = 0.010, P = 0.040, respectively). VEGF overexpression was more frequently observed in the old age group (≥ 60 years old) and the intestinal type (P = 0.013, P = 0.014, respectively). However, correlations between preoperative sVEGF level and tissue HIF-1α, VEGF, and p53 were not observed. The median follow-up duration after operation was 24.5 months. HIF-1α was observed to be a poor prognostic factor of disease recurrence or progression (P = 0.002). p53, HIF-1α and preoperative sVEGF might be markers of depth of invasion or lymph node involvement. HIF-1α expression was a poor prognostic factor of disease recurrence or progression in patients with gastric cancers.
登录
查看更多内容
影响因子:
3
作者:
Hashimoto, H;Akimoto, M;Yamashito, K
通讯作者:
Yamashito, K
影响因子:
8.8
作者:
Fondevila, C;Metges, J P;Fuster, J;Grau, J J;Palacin, A;Castells, A;Volant, A;Pera, M
通讯作者:
Pera, M
影响因子:
9.7
作者:
Nakayama, K;Kanzaki, A;Takebayashi, Y
通讯作者:
Takebayashi, Y
影响因子:
5.7
作者:
Konno, H;Ohta, M;Nakamura, S
通讯作者:
Nakamura, S
影响因子:
1.6
作者:
Baba, M;Konno, H;Baba, S
通讯作者:
Baba, S